BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35008777)

  • 1. Concomitant Activation of OSM and LIF Receptor by a Dual-Specific hlOSM Variant Confers Cardioprotection after Myocardial Infarction in Mice.
    Lörchner H; Adrian-Segarra JM; Waechter C; Wagner R; Góes ME; Brachmann N; Sreenivasan K; Wietelmann A; Günther S; Doll N; Braun T; Pöling J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
    Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M is a growth factor for Ewing sarcoma.
    David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
    Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
    Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
    J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.
    Kubin T; Gajawada P; Bramlage P; Hein S; Berge B; Cetinkaya A; Burger H; Schönburg M; Schaper W; Choi YH; Richter M
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.
    Feng Y; Yuan Y; Xia H; Wang Z; Che Y; Hu Z; Deng J; Li F; Wu Q; Bian Z; Zhou H; Shen D; Tang Q
    J Transl Med; 2023 Apr; 21(1):290. PubMed ID: 37120549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
    Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
    J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
    Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition.
    Lantieri F; Bachetti T
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered interleukin-6-derived cytokines recruit artificial receptor complexes and disclose CNTF signaling via the OSMR.
    Rafii P; Cruz PR; Ettich J; Seibel C; Padrini G; Wittich C; Lang A; Petzsch P; Köhrer K; Moll JM; Floss DM; Scheller J
    J Biol Chem; 2024 May; 300(5):107251. PubMed ID: 38569939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.
    Walker EC; McGregor NE; Poulton IJ; Solano M; Pompolo S; Fernandes TJ; Constable MJ; Nicholson GC; Zhang JG; Nicola NA; Gillespie MT; Martin TJ; Sims NA
    J Clin Invest; 2010 Feb; 120(2):582-92. PubMed ID: 20051625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
    Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
    J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
    Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
    J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
    Hsu MP; Frausto R; Rose-John S; Campbell IL
    Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
    Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
    J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
    Ichihara M; Hara T; Kim H; Murate T; Miyajima A
    Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.